Uncategorized
Aptar Pharma’s Preservative-Free Multidose Dispenser Chosen for the First Time for a Prescription Dry Eye Product in the US with RESTASIS MULTIDOSE™
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the U.S. prescription market for the first time with Allergan’s RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05%. This approval and launch makes the Aptar Pharma Ophthalmic Squeeze Dispenser the very first, and only, U.S. FDA-approved multidose delivery system to handle prescription eye treatment formulations without any pr